SEC Company Response from ANGIOTECH PHARMACEUTICALS INC (CIK 0001096481) — Sep 25, 2003
ANGIOTECH PHARMACEUTICALS INC (CIK 0001096481)
Date: Sept. 25, 2003 · CIK: 0001096481 · Accession: 0001047469-03-031685
AI Filing Summary & Sentiment
Show Raw Text
CORRESP 1 filename1.htm QuickLinks -- Click here to rapidly navigate through this document [LETTERHEAD OF BRITISH COLUMBIA SECURITIES COMMISSION] IN THE MATTER OF NATIONAL POLICY 43-201 MUTUAL RELIANCE REVIEW SYSTEM FOR PROSPECTUSES AND ANNUAL INFORMATION FORMS AND IN THE MATTER OF ANGIOTECH PHARMACEUTICALS, INC. DECISION DOCUMENT This final mutual reliance review system decision document evidences that final receipts of the regulators in each of British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, and Newfoundland and Labrador have been issued for a short form base prep prospectus, of the above issuer dated September 25, 2003. DATED at Vancouver, British Columbia on September 25, 2003. Tracy Hedberg Tracy Hedberg Senior Securities Analyst Corporate Finance Branch SEDAR Project No.: 574860 QuickLinks IN THE MATTER OF NATIONAL POLICY 43-201 MUTUAL RELIANCE REVIEW SYSTEM FOR PROSPECTUSES AND ANNUAL INFORMATION FORMS